ISSN: 2161-0460

Journal of Alzheimers Disease & Parkinsonism
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Michael Ropacki

Janssen R&D, South San Francisco, CA, USA

Biography

Dr. Michael Ropacki is the President of a San Francisco based consultancy firm, Strategic Global Research & Development (SGR&D) that collaborates with sponsors developing and executing Clinical Development Plans to optimize regulatory interactions. Prior to his role at SGR&D, Dr. Ropacki was most recently Senior Vice President of Clinical Development at MedAvante-ProPhase.
Research Interest

 Alzheimer’s disease; Parkinson’s disease; Therapy development; Precompetitive consortium

Publications
https://bahigox.fun/ https://bahisjet.fun/ https://bahsegel.fun/ https://betboo.fun/ https://betdoksan.xyz/ https://betebetgiris.xyz/ https://betexper.fun/ https://betgram.fun/ https://betkanyon.fun/ https://betkolik.fun/
Top